Press Releases

You'll find below all the official Press Releases from Ceva.

22 July 2014

Mid-year results >

Ceva attracts strong investor support for 4th LMBO and returns to double-digit growth in first 6 months of 2014

10 June 2014

Ceva Santé Animale reorganizes its capital structure to bolster its international ambitions >

Libourne, June 11, 2014: The management of Ceva Santé Animale announces a reshaping of its capital structure through a new round of financing which strengthens its position as majority shareholder and welcomes new investors to support the group in a new phase of development. The new capital structure paves the way to the entry of Temasek who will invest alongside the managementas well as French...

7 May 2014

Ceva proposes new respiratory health programs for swine >

Symposium held prior to ESPHM presents benefits of more targeted vaccination

29 April 2014

Ceva hosts 2nd. Biotech Innovation day in the US >

Industrial know-­how partners emphasize benefits of working together

30 January 2014

Co-operation in Hungary to prevent zoonosis >

A conference was held in Budapest to facilitate the control of diseases transmissible from animals to humans

9 January 2014

Jérôme-André Gauthier, new Strategy and Business Development Director >

Jérôme-André Gauthier joins the Executive Committee team at Ceva Santé Animale as the new Strategy and Business Development Director, starting January 1st, 2014.

19 December 2013

Ceva acquires Sogeval >

Sogeval, a subsidiary of Sofiprotéol, joins veterinary firm Ceva Santé Animale with a view to creating one of the world leaders in veterinary pharmacy.

22 September 2013

Ceva launches Fertipig® in Asia >

New product gives swine producers “power with control”

21 July 2013

Ceva’s growth continues despite difficult market conditions >

Libourne, France, 22 July, 2013: Consolidated sales of the Ceva Group reached €310m in the first 6 months of 2013, up by 2%, 4.2% on the previous year at a constant perimeter and exchange rates. Ceva recorded solid growth of 9% on a constant basis (constant perimeter and exchange rates), if one excludes 2 factors:  Vectra® sales in the United States, which were less than anticipated, due to a...

12 June 2013

Ceva signs a Joint-venture agreement in China to help control zoonoses >

Joint-venture with Jinyu Baoling will produce brucellosis vaccines in Inner Mongolia

Back to top